Cytocast logo

Cytocast

REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THROUGH CELL SIMULATION

19 employees · est. 2019 · Budapest, Hungary

VS
Ro5 logo

Ro5

Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.

12 employees · est. 2018 · London, United Kingdom

Ro5 is the older company (2019 vs 2018).

Side-by-Side Comparison

Cytocast Ro5
Founded
2019 2018 older
Headquarters
Budapest, Hungary London, United Kingdom
Employees
19 12
Industry
Biotechnology, Health Care, Medical Devices AI, Biotechnology, Health Care
Funding Stage
Pre Seed Seed
Total Funding
$1.86M Not tracked yet
Funding Rounds
3 3
Services
Not tracked yet Development of innovative medicines targeting core aging mechanisms, Clinical-stage drug trials, AI-enabled R&D for drug discovery and development, Adaptive clinical trial design
Target Customers
Not tracked yet Investors seeking high returns in biopharma, Healthcare providers focusing on longevity and preventive care, Institutions looking for innovative aging treatments, Pharmaceutical companies interested in strategic collaborations
Taxonomy
Bioinformatics, Drug Discovery, Personalized Treatment, Budapest, Patient Data, Computer Models, Cellular Health AI In Drug Discovery, De Novo Drug Discovery, ADMET Analysis, Knowledge Graphs, Digital Transformation In Pharma, R&D Software Solutions, Data-Driven Decision Making, Workflow Augmentation, Pharmaceutical Software Development, Clinical Trial Analytics, Bioactivity Analysis, Hit Identification, Lead Optimization, Cheminformatics, Computational Chemistry
Website
cytocast.com Ro5.ai
Cytocast logo

About Cytocast

Cytocast is a TechBio startup company founded in 2019, headquartered in Hungary. The company's slogan, "Safer and Smarter Drug Development - Transforming drug development and precision medicine with advanced cell simulation," reflects its mission to revolutionize drug development and precision medic...

Ro5 logo

About Ro5

Ro5, founded in 2018 and headquartered in the United Kingdom, is making significant strides in the intersection of AI, Biotechnology, and Pharmaceutical industries. With its compelling slogan, "Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.", Ro5 positions itself as a pioneering force...

We will tell you when either one moves

BounceWatch watches Cytocast and Ro5 for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cytocast and Ro5 — by email.

Frequently Asked Questions

Cytocast — REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THROUGH CELL SIMULATION . Ro5 — Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cytocast has raised $1.86M while Ro5 has raised undisclosed funding.
Cytocast and Ro5 operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cytocast with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cytocast on 11 Sep 2024, and Ro5 on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy